Bionic Devices Market Report
RA00697
Bionic Devices Market, by Product (Ear Bionic Devices, Middle Ear Implant (MEI), Cochlear Implant (CI), Electro-Acoustic Stimulation (EAS) Implant, Auditory Brainstem Implant (ABI), Orthopedic Bionic Devices, Legs, Hands, Cardiac Devices, Total Artificial Heart, Biological (Bioprosthetic/Tissue), Tissue-Engineered Valves, Ventricular Assist Devices (Vads), Pacemaker, Brain Devices, Eye Bionic Devices, Others), End Use (Hospitals & Clinics, Research & Academic Institutes, Others), Material (Tungsten, Silicon, Platinum-Iridium, Stainless Steel, Biologics), Fixation (Implantable Bionics, External Bionics): Global Opportunity Analysis and Industry Forecast, 2020-2027
The global bionic devices market is estimated to surpass $42,921.7 million by 2027, exhibiting a CAGR of 9.8% from 2020 to 2027.
OFFERINGS OF THE REPORT
The report offers a clear view of the present scenario and future growth of the global bionic devices market. The report delivers an exclusive analysis of global bionic devices market by studying several factors of the market such as key segments, market dynamics, regional market circumstances, investment suitability, and foremost players operating in the market. Moreover, the report offers sharp insights into present and prospective trends & developments in the market.
Moreover, the report articulates key opportunities and factors fueling the market growth. The limitations and threatening factors that have the possibility to impede the market growth are described in the report.
The report reveals statistics by mentioning the predicted market size and forecast by assessing every segment of the global bionic devices market. Regional market analysis of these segments is also provided in the report. The report segments the global bionic devices market into four main geographical territories including Asia-Pacific, Europe, North America, and LAMEA. These regions are further sub-divided to offer an exhaustive update of the bionic devices market across the respective regions.
In addition to these insights, the profiles of top players active in the global bionic devices market are articulated in the report. An exhaustive summary of 10 foremost players functioning in the global bionic devices market is delivered to comprehend their position and footmark in the market. The report also provides insights into some of the most recent advancements of the industry.
The report highlights various data points such as short summary of the company, chief company executives, company’s financial status and proceeds, key business strategies executed by company, advanced developments or initiatives taken by company to thrust their position and grasp a remarkable position in the global bionic devices market. Moreover. Porter’s five forces analysis that explains the bargaining power of consumers and suppliers, competitive landscape, threats of new players, and development of substitutes in the market is also mentioned in the report.
KEY TAKEWAYS FROM THE REPORT
- The report offers the market statistics for the period from 2019 to 2027
- This report delivers inventions, trends, and innovative developments along with an exhaustive quantitative analysis of the bionic devices market during the period of forecast
- The prevailing and forthcoming investment opportunities along with the strategic assessment of the global bionic devices market growth is delivered
- The market size and forecasts are derived by scrutinizing market boomers and restraints, and key developments in the bionic devices market
- Insights into foremost market players, Porter’s Five Analysis, and top winning business strategies is provided
- Growth tactics and initiatives taken by the top market players are outlined to understand the competitive scenario and strength of the market
KEY MARKET SEGMENTS
The report segments the global market into product ,end use ,material ,fixation and region. (Varies depending on market)
- Product: Ear Bionic Devices, Middle Ear Implant (MEI), Cochlear Implant (CI), Electro-Acoustic Stimulation (EAS) Implant, Auditory Brainstem Implant (ABI), Orthopedic Bionic Devices, Legs, Hands, Cardiac Devices, Total Artificial Heart, Biological (Bioprosthetic/Tissue), Tissue-Engineered Valves, Ventricular Assist Devices (Vads), Pacemaker, Brain Devices, Eye Bionic Devices, Others
- End Use: Hospitals & Clinics, Research & Academic Institutes, Others
- Material: Tungsten, Silicon, Platinum-Iridium, Stainless Steel, Biologics
- Fixation: Implantable Bionics, External Bionics
Region,
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Argentina
- Saudi Arabia
- South Africa
- UAE
- Rest of LAMEA
KEY PLAYERS AND BUSINESS STRATEGIES
The leading players of the global bionic devices market are included in the report. They are Cochlear Ltd., Retina Implant AG, Medtronic plc, SECOND SIGHT. The report summarizes the business overview including financial and annual performance, newest strategic plans & developments, product range, and SWOT analysis of all the players mentioned in the report.
1. Abbott
2. Boston Scientific Corporation
3. Cochlear Ltd.
4. LivaNova PLC
5. Medtronic plc
6. Orthofix Holdings, Inc.
7. ssur Corporate
8. Retina Implant AG
9. Sonova
10. SECOND SIGHT
11. SynCardia Systems, LLC
12. William Demant Holding A/S
RESEARCH METHODOLOGY
The research report is drafted by in-house research analysts who sincerely examine the market scenario and form predictions. The market forecasts specified in the report have been derived using proven research approaches and analytical models & tools. The use of such pioneering and effective tools helps market analysts in analyzing, filtering, and providing highly precise statistics and estimates. The report provides an extensive research and analysis backed with factual data obtained from various interviews with market players, reliable and renowned sources of data, and regional intelligence. The insights delivered in the report can help stakeholders in understanding investment suitability and market players to seize opportunities for partnerships, investments, and advancements in the global market.
The research report is formulated by collecting different information, news, and statistics about the bionic devices market. For instance, detailed interviews and discussions with veteran market players and stakeholders, including upstream and downstream members have been conducted to obtain reliable and realistic data. Even though primary research forms the crucial part of the research report, secondary research plays a significant role in backing the research outcomes. Nearly 5,900 product type literatures, business magazines, company annual reports, and other such significant documents of leading market players have been considered and studied for thorough understanding of the market scenario. In addition, truthful industry bulletins, medical newsletters, trade associations’ journals, and government websites have been explored for tracking down high-value market insights.
-
1. RESEARCH METHODOLOGY
1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters
1.5. Market size estimation
1.5.1. Top-down approach
1.5.2. Bottom-up approach
-
2. REPORT SCOPE
2.1. Market definition
2.2. Key objectives of the study
2.3. Report overview
2.4. Market segmentation
2.5. Overview of the impact of COVID-19 on Global Bionic Devices Market
-
3. EXECUTIVE SUMMARY
-
4. MARKET OVERVIEW
4.1. Introduction
4.2. Growth impact forces
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Market value chain analysis
4.3.1. List of raw material suppliers
4.3.2. List of manufacturers
4.3.3. List of distributors
4.4. Innovation & sustainability matrices
4.4.1. Technology matrix
4.4.2. Regulatory matrix
4.5. Porter’s five forces analysis
4.5.1. Bargaining power of suppliers
4.5.2. Bargaining power of consumers
4.5.3. Threat of substitutes
4.5.4. Threat of new entrants
4.5.5. Competitive rivalry intensity
4.6. PESTLE analysis
4.6.1. Political
4.6.2. Economical
4.6.3. Social
4.6.4. Technological
4.6.5. Environmental
4.7. Impact of COVID-19 on Bionic Devices Market
4.7.1. Pre-covid market scenario
4.7.2. Post-covid market scenario
-
5. Bionic Devices Market, By End Use
5.1. Overview
5.2 Ear Bionic Devices
5.2.1 Definition, key trends, growth factors, and opportunities
5.2.2 Market size analysis, by region, 2020-2027
5.2.3 Market share analysis, by country, 2020-2027
5.3 Middle Ear Implant (MEI)
5.3.1 Definition, key trends, growth factors, and opportunities
5.3.2 Market size analysis, by region, 2020-2027
5.3.3 Market share analysis, by country, 2020-2027
5.4 Cochlear Implant (CI)
5.4.1 Definition, key trends, growth factors, and opportunities
5.4.2 Market size analysis, by region, 2020-2027
5.4.3 Market share analysis, by country, 2020-2027
5.5 Electro-Acoustic Stimulation (EAS) Implant
5.5.1 Definition, key trends, growth factors, and opportunities
5.5.2 Market size analysis, by region, 2020-2027
5.5.3 Market share analysis, by country, 2020-2027
5.6 Auditory Brainstem Implant (ABI)
5.6.1 Definition, key trends, growth factors, and opportunities
5.6.2 Market size analysis, by region, 2020-2027
5.6.3 Market share analysis, by country, 2020-2027
5.7 Orthopedic Bionic Devices
5.7.1 Definition, key trends, growth factors, and opportunities
5.7.2 Market size analysis, by region, 2020-2027
5.7.3 Market share analysis, by country, 2020-2027
5.8 Legs
5.8.1 Definition, key trends, growth factors, and opportunities
5.8.2 Market size analysis, by region, 2020-2027
5.8.3 Market share analysis, by country, 2020-2027
5.9 Hands
5.9.1 Definition, key trends, growth factors, and opportunities
5.9.2 Market size analysis, by region, 2020-2027
5.9.3 Market share analysis, by country, 2020-2027
5.10 Cardiac Devices
5.10.1 Definition, key trends, growth factors, and opportunities
5.10.2 Market size analysis, by region, 2020-2027
5.10.3 Market share analysis, by country, 2020-2027
5.11 Total Artificial Heart
5.11.1 Definition, key trends, growth factors, and opportunities
5.11.2 Market size analysis, by region, 2020-2027
5.11.3 Market share analysis, by country, 2020-2027
5.12 Biological (Bioprosthetic/Tissue)
5.12.1 Definition, key trends, growth factors, and opportunities
5.12.2 Market size analysis, by region, 2020-2027
5.12.3 Market share analysis, by country, 2020-2027
5.13 Tissue-Engineered Valves
5.13.1 Definition, key trends, growth factors, and opportunities
5.13.2 Market size analysis, by region, 2020-2027
5.13.3 Market share analysis, by country, 2020-2027
5.14 Ventricular Assist Devices (Vads)
5.14.1 Definition, key trends, growth factors, and opportunities
5.14.2 Market size analysis, by region, 2020-2027
5.14.3 Market share analysis, by country, 2020-2027
5.15 Pacemaker
5.15.1 Definition, key trends, growth factors, and opportunities
5.15.2 Market size analysis, by region, 2020-2027
5.15.3 Market share analysis, by country, 2020-2027
5.16 Brain Devices
5.16.1 Definition, key trends, growth factors, and opportunities
5.16.2 Market size analysis, by region, 2020-2027
5.16.3 Market share analysis, by country, 2020-2027
5.17 Eye Bionic Devices
5.17.1 Definition, key trends, growth factors, and opportunities
5.17.2 Market size analysis, by region, 2020-2027
5.17.3 Market share analysis, by country, 2020-2027
5.18 Others
5.18.1 Definition, key trends, growth factors, and opportunities
5.18.2 Market size analysis, by region, 2020-2027
5.18.3 Market share analysis, by country, 2020-2027
5.19 Research Dive Exclusive Insights
5.19.1 Market attractiveness
5.19.2 Competition heatmap
-
6. Bionic Devices Market, By Application
6.1. Overview
6.2 Hospitals & Clinics
6.2.1 Definition, key trends, growth factors, and opportunities
6.2.2 Market size analysis, by region, 2020-2027
6.2.3 Market share analysis, by country, 2020-2027
6.3 Research & Academic Institutes
6.3.1 Definition, key trends, growth factors, and opportunities
6.3.2 Market size analysis, by region, 2020-2027
6.3.3 Market share analysis, by country, 2020-2027
6.4 Others
6.4.1 Definition, key trends, growth factors, and opportunities
6.4.2 Market size analysis, by region, 2020-2027
6.4.3 Market share analysis, by country, 2020-2027
6.5 Research Dive Exclusive Insights
6.5.1 Market attractiveness
6.5.2 Competition heatmap
-
7. Bionic Devices Market, By Portability
7.1. Overview
7.2 Tungsten
7.2.1 Definition, key trends, growth factors, and opportunities
7.2.2 Market size analysis, by region, 2020-2027
7.2.3 Market share analysis, by country, 2020-2027
7.3 Silicon
7.3.1 Definition, key trends, growth factors, and opportunities
7.3.2 Market size analysis, by region, 2020-2027
7.3.3 Market share analysis, by country, 2020-2027
7.4 Platinum-Iridium
7.4.1 Definition, key trends, growth factors, and opportunities
7.4.2 Market size analysis, by region, 2020-2027
7.4.3 Market share analysis, by country, 2020-2027
7.5 Stainless Steel
7.5.1 Definition, key trends, growth factors, and opportunities
7.5.2 Market size analysis, by region, 2020-2027
7.5.3 Market share analysis, by country, 2020-2027
7.6 Biologics
7.6.1 Definition, key trends, growth factors, and opportunities
7.6.2 Market size analysis, by region, 2020-2027
7.6.3 Market share analysis, by country, 2020-2027
7.7 Research Dive Exclusive Insights
7.7.1 Market attractiveness
7.7.2 Competition heatmap
-
8. Bionic Devices Market, By Policy Coverage
8.1. Overview
8.2 Implantable Bionics
8.2.1 Definition, key trends, growth factors, and opportunities
8.2.2 Market size analysis, by region, 2020-2027
8.2.3 Market share analysis, by country, 2020-2027
8.3 External Bionics
8.3.1 Definition, key trends, growth factors, and opportunities
8.3.2 Market size analysis, by region, 2020-2027
8.3.3 Market share analysis, by country, 2020-2027
8.4 Research Dive Exclusive Insights
8.4.1 Market attractiveness
8.4.2 Competition heatmap
9. Bionic Devices Market, By Region
9.1 North America
9.1.1 U.S
9.1.1.1 Market size analysis, By End Use, 2020-2027
9.1.1.2 Market size analysis, By Application, 2020-2027
9.1.1.3 Market size analysis, By Portability, 2020-2027
9.1.1.4 Market size analysis, By Policy Coverage, 2020-2027
9.1.2 Canada
9.1.2.1 Market size analysis, By End Use, 2020-2027
9.1.2.2 Market size analysis, By Application, 2020-2027
9.1.2.3 Market size analysis, By Portability, 2020-2027
9.1.2.4 Market size analysis, By Policy Coverage, 2020-2027
9.1.3 Mexico
9.1.3.1 Market size analysis, By End Use, 2020-2027
9.1.3.2 Market size analysis, By Application, 2020-2027
9.1.3.3 Market size analysis, By Portability, 2020-2027
9.1.3.4 Market size analysis, By Policy Coverage, 2020-2027
9.1.4 Research Dive Exclusive Insights
9.1.4.1 Market attractiveness
9.1.4.2 Competition heatmap
9.2 Europe
9.2.1 Germany
9.2.1.1 Market size analysis, By End Use, 2020-2027
9.2.1.2 Market size analysis, By Application, 2020-2027
9.2.1.3 Market size analysis, By Portability, 2020-2027
9.2.1.4 Market size analysis, By Policy Coverage, 2020-2027
9.2.2 UK
9.2.2.1 Market size analysis, By End Use, 2020-2027
9.2.2.2 Market size analysis, By Application, 2020-2027
9.2.2.3 Market size analysis, By Portability, 2020-2027
9.2.2.4 Market size analysis, By Policy Coverage, 2020-2027
9.2.3 France
9.2.3.1 Market size analysis, By End Use, 2020-2027
9.2.3.2 Market size analysis, By Application, 2020-2027
9.2.3.3 Market size analysis, By Portability, 2020-2027
9.2.3.4 Market size analysis, By Policy Coverage, 2020-2027
9.2.4 Spain
9.2.4.1 Market size analysis, By End Use, 2020-2027
9.2.4.2 Market size analysis, By Application, 2020-2027
9.2.4.3 Market size analysis, By Portability, 2020-2027
9.2.4.4 Market size analysis, By Policy Coverage, 2020-2027
9.2.5 Italy
9.2.5.1 Market size analysis, By End Use, 2020-2027
9.2.5.2 Market size analysis, By Application, 2020-2027
9.2.5.3 Market size analysis, By Portability, 2020-2027
9.2.5.4 Market size analysis, By Policy Coverage, 2020-2027
9.2.6 Rest of Europe
9.2.6.1 Market size analysis, By End Use, 2020-2027
9.2.6.2 Market size analysis, By Application, 2020-2027
9.2.6.3 Market size analysis, By Portability, 2020-2027
9.2.6.4 Market size analysis, By Policy Coverage, 2020-2027
9.2.7 Research Dive Exclusive Insights
9.2.7.1 Market attractiveness
9.2.7.2 Competition heatmap
9.3 Asia-Pacific
9.3.1 China
9.3.1.1 Market size analysis, By End Use, 2020-2027
9.3.1.2 Market size analysis, By Application, 2020-2027
9.3.1.3 Market size analysis, By Portability, 2020-2027
9.3.1.4 Market size analysis, By Policy Coverage, 2020-2027
9.3.2 Japan
9.3.2.1 Market size analysis, By End Use, 2020-2027
9.3.2.2 Market size analysis, By Application, 2020-2027
9.3.2.3 Market size analysis, By Portability, 2020-2027
9.3.2.4 Market size analysis, By Policy Coverage, 2020-2027
9.3.3 India
9.3.3.1 Market size analysis, By End Use, 2020-2027
9.3.3.2 Market size analysis, By Application, 2020-2027
9.3.3.3 Market size analysis, By Portability, 2020-2027
9.3.3.4 Market size analysis, By Policy Coverage, 2020-2027
9.3.4 Australia
9.3.4.1 Market size analysis, By End Use, 2020-2027
9.3.4.2 Market size analysis, By Application, 2020-2027
9.3.4.3 Market size analysis, By Portability, 2020-2027
9.3.4.4 Market size analysis, By Policy Coverage, 2020-2027
9.3.5 South Korea
9.3.5.1 Market size analysis, By End Use, 2020-2027
9.3.5.2 Market size analysis, By Application, 2020-2027
9.3.5.3 Market size analysis, By Portability, 2020-2027
9.3.5.4 Market size analysis, By Policy Coverage, 2020-2027
9.3.6 Rest of Asia-Pacific
9.3.6.1 Market size analysis, By End Use, 2020-2027
9.3.6.2 Market size analysis, By Application, 2020-2027
9.3.6.3 Market size analysis, By Portability, 2020-2027
9.3.6.4 Market size analysis, By Policy Coverage, 2020-2027
9.3.7 Research Dive Exclusive Insights
9.3.7.1 Market attractiveness
9.3.7.2 Competition heatmap
9.4 LAMEA
9.4.1 Brazil
9.4.1.1 Market size analysis, By End Use, 2020-2027
9.4.1.2 Market size analysis, By Application, 2020-2027
9.4.1.3 Market size analysis, By Portability, 2020-2027
9.4.1.4 Market size analysis, By Policy Coverage, 2020-2027
9.4.2 Saudi Arabia
9.4.2.1 Market size analysis, By End Use, 2020-2027
9.4.2.2 Market size analysis, By Application, 2020-2027
9.4.2.3 Market size analysis, By Portability, 2020-2027
9.4.2.4 Market size analysis, By Policy Coverage, 2020-2027
9.4.3 UAE
9.4.3.1 Market size analysis, By End Use, 2020-2027
9.4.3.2 Market size analysis, By Application, 2020-2027
9.4.3.3 Market size analysis, By Portability, 2020-2027
9.4.3.4 Market size analysis, By Policy Coverage, 2020-2027
9.4.4 South Africa
9.4.4.1 Market size analysis, By End Use, 2020-2027
9.4.4.2 Market size analysis, By Application, 2020-2027
9.4.4.3 Market size analysis, By Portability, 2020-2027
9.4.4.4 Market size analysis, By Policy Coverage, 2020-2027
9.4.5 Rest of LAMEA
9.4.5.1 Market size analysis, By End Use, 2020-2027
9.4.5.2 Market size analysis, By Application, 2020-2027
9.4.5.3 Market size analysis, By Portability, 2020-2027
9.4.5.4 Market size analysis, By Policy Coverage, 2020-2027
9.4.6 Research Dive Exclusive Insights
9.4.6.1 Market attractiveness
9.4.6.2 Competition heatmap
10. Competitive Landscape
10.1 Top winning strategies, 2020-2027
10.1.1 By strategy
10.1.2 By year
10.2 Strategic overview
10.3 Market share analysis, 2020-2027
11. Company Profiles
11.1 Abbott
11.1.1 Overview
11.1.2 Business segments
11.1.3 Product portfolio
11.1.4 Financial performance
11.1.5 Recent developments
11.1.6 SWOT analysis
11.2 Boston Scientific Corporation
11.2.1 Overview
11.2.2 Business segments
11.2.3 Product portfolio
11.2.4 Financial performance
11.2.5 Recent developments
11.2.6 SWOT analysis
11.3 Cochlear Ltd.
11.3.1 Overview
11.3.2 Business segments
11.3.3 Product portfolio
11.3.4 Financial performance
11.3.5 Recent developments
11.3.6 SWOT analysis
11.4 LivaNova PLC
11.4.1 Overview
11.4.2 Business segments
11.4.3 Product portfolio
11.4.4 Financial performance
11.4.5 Recent developments
11.4.6 SWOT analysis
11.5 Medtronic plc
11.5.1 Overview
11.5.2 Business segments
11.5.3 Product portfolio
11.5.4 Financial performance
11.5.5 Recent developments
11.5.6 SWOT analysis
11.6 Orthofix Holdings, Inc.
11.6.1 Overview
11.6.2 Business segments
11.6.3 Product portfolio
11.6.4 Financial performance
11.6.5 Recent developments
11.6.6 SWOT analysis
11.7 ssur Corporate
11.7.1 Overview
11.7.2 Business segments
11.7.3 Product portfolio
11.7.4 Financial performance
11.7.5 Recent developments
11.7.6 SWOT analysis
11.8 Retina Implant AG
11.8.1 Overview
11.8.2 Business segments
11.8.3 Product portfolio
11.8.4 Financial performance
11.8.5 Recent developments
11.8.6 SWOT analysis
11.9 Sonova
11.9.1 Overview
11.9.2 Business segments
11.9.3 Product portfolio
11.9.4 Financial performance
11.9.5 Recent developments
11.9.6 SWOT analysis
11.10 SECOND SIGHT
11.10.1 Overview
11.10.2 Business segments
11.10.3 Product portfolio
11.10.4 Financial performance
11.10.5 Recent developments
11.10.6 SWOT analysis
11.11 SynCardia Systems, LLC
11.11.1 Overview
11.11.2 Business segments
11.11.3 Product portfolio
11.11.4 Financial performance
11.11.5 Recent developments
11.11.6 SWOT analysis
11.12 William Demant Holding A/S
11.12.1 Overview
11.12.2 Business segments
11.12.3 Product portfolio
11.12.4 Financial performance
11.12.5 Recent developments
11.12.6 SWOT analysis
Personalize this research
- Triangulate with your own data
- Request your format and definition
- Get a deeper dive on a specific application, geography, customer or competitor
- + 1-888-961-4454 Toll - Free
- support@researchdive.com
